Contrast nephropathy in cancer patients receiving anti-VEGF therapy: a prospective study.
Ali GökyerAhmet KüçükardaOsman KöstekMuhammet Bekir HacıoğluSernaz UzunoğluOsman KulaNazmi KurtSedat ÜstündağBülent Erdoğanİrfan ÇiçinPublished in: International journal of clinical oncology (2020)
CIN was significantly more frequent in cancer patients who receiving anti-VEGF/R drugs than those not receiving anti-VEGF/R drugs.